NASDAQ: DAWN - Day One Biopharmaceuticals, Inc.

Lønnsomhet i seks måneder: -25.18%
Sektor: Healthcare

Kampanjeplan Day One Biopharmaceuticals, Inc.


Om selskapet

Биофармацевтическая компания Day One Biopharmaceuticals, Inc., работающая на клинической стадии, разрабатывает и коммерциализирует таргетные методы лечения пациентов с генетически определенным раком. Его ведущим кандидатом на продукцию является DAY101, пероральный ингибитор быстро ускоряющейся киназы фибросаркомы типа II, проникающий в мозг, который проходит клинические испытания фазы II для педиатрических пациентов с рецидивирующей / прогрессирующей глиомой низкой степени злокачественности.

flere detaljer
Компания также разрабатывает Pimasertib, пероральный низкомолекулярный ингибитор митоген-активируемых протеинкиназ киназ 1 и 2. Day One Biopharmaceuticals, Inc. была в 2018 году, ее штаб-квартира находится в Южном Сан-Франциско, Калифорния.

IPO date 2021-05-27
ISIN US23954D1090
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт http://dayonebio.com
Цена ао 11.71
Prisendring per dag: -0.7627% (11.8)
Prisendring per uke: -4.02% (12.2)
Prisendring per måned: -8.59% (12.81)
Prisendring over 3 måneder: -18.11% (14.3)
Prisendring over seks måneder: -25.18% (15.65)
Prisendring per år: -16% (13.94)
Prisendring over 3 år: -20.39% (14.71)
Prisendring over 5 år: -0% (11.71)
Prisendring over 10 år: -0% (11.71)
Prisendring siden begynnelsen av året: -7.72% (12.69)

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 3.54 5
P/E 4.18 10
EV/EBITDA -4.84 0
Total: 5.38

Effektivitet

Navn Betydning Karakter
ROA, % -50.24 0
ROE, % -54.52 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.002 10
Total: 7.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 1282.98 10
Lønnsomhet EPS, % 383.3 10
Total: 8

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Virtus LifeSci Biotech Products ETF 1.60585 36.79 0.13953
Range Cancer Therapeutics ETF 1.32832 47.24 0.11955
Direxion Daily S&P Biotech Bull 3x Shares 0.17389 4067.92 0.25924
Future Tech ETF 0.14317 426.34 0.8416
Principal Healthcare Innovators ETF 0.14317 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.12064 28.58 0.8565
Vanguard U.S. Momentum Factor ETF 0.09 27.18 1.05834
ProShares Ultra Nasdaq Biotechnology 0.08009 51.7 0.85651
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.05528 24.75 1.59225
iShares Russell 2000 Growth ETF 0.05129 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.05 17.39 0.60264
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.04617 16.5 1.66828
Vanguard Russell 2000 ETF 0.03 14.37 1.48801
iShares Morningstar Small-Cap Growth ETF 0.02178 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.02178 590.83 0.72598
Schwab U.S. Small-Cap ETF 0.02057 13.35 1.51433
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.01973 31.36 1.41955
iShares Morningstar Small-Cap ETF 0.01885 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.01885 391.25 1.60498
ProShares UltraPro Russell2000 0.01657 89.82 1.47873
iShares Morningstar Small Cap Value ETF 0.01569 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.01569 199.14 2.50476
Fidelity MSCI Health Care Index ETF 0.01193 0.1657 1.46057
Vanguard Small Cap Value ETF 0.01 12.41 2.19419
Dimensional U.S. Core Equity 2 ETF 0.00733 30.76 1.47098
Humankind US Stock ETF 0.00635 18.81 1.99919
ProShares Hedge Replication ETF 0.00439 5.92 1.47892
Dimensional US Core Equity Market ETF 0.00263 30.98 1.40618
iShares Russell 3000 ETF 0.00182 23.61 1.43482
Schwab U.S. Broad Market ETF 0.00143 23.7 1.43354
Avantis U.S. Equity ETF 0.00124 20.45 1.59151
Dimensional U.S. Equity ETF 0.00097 31.53 1.3557
Vanguard Russell 3000 ETF 0 31.87 1.43817



Veileder Stillingstittel Betaling Fødselsår
Dr. Jeremy Bender M.B.A., Ph.D. CEO, President & Director 900k 1971 (54 år)
Dr. Samuel C. Blackman M.D., Ph.D. Co-Founder and Head of R&D 651k 1969 (56 år)
Dr. Davy Chiodin Ph.D., Pharm.D. Chief Development Officer N/A
Ms. Jaa Roberson Chief People Officer N/A
Mr. Adam Dubow General Counsel and Chief Compliance Officer N/A 1967 (58 år)
Ms. Lauren Merendino M.B.A. Chief Commercial Officer N/A 1976 (49 år)
Dr. Elly Barry M.D. Chief Medical Officer N/A
Mr. Charles N. York II, M.B.A. COO, CFO & Secretary 1977 (48 år)
Mr. John Stubenrauch Ph.D. Chief Technology Officer

Adresse: United States, South San Francisco, CA -, 395 Oyster Point Boulevard - åpne i Google maps, åpne Yandex-kart
Nettsted: http://dayonebio.com